PATIENT FRIENDLY TELEPHONE LINKED BLOOD PRESSURE MONITOR

这是一项改进和评估一项旨在 以低于当前成本的价格改善高血压护理。高血压是 这是影响心脏病的最常见的疾病之一。 1995年，美国治疗高血压的费用约为187亿美元。 尽管有大量有效的降压药，但明确 有证据表明，使用它们可以降低与高血压相关的发病率， 据估计，只有四分之一的美国高血压患者患有高血压。 控制得很好。这是一项将临床级 具有非常低成本的专有电子家用血压计 我们开发的远程传输系统，使患者能够 轻松地将血压和心率数据发送给医生 电话线。这些用户友好的技术将嵌入到 自动化信息管理系统，将转移护理地点 从临床到家庭，提高医生和家庭的能力 帮助患者评估和管理高血压。我们预计每月5美元的成本是 用户为整个系统，包括监控和电信。 拟议的商业应用：我们的服务将允许管理式医疗 企业通过改善患者状况来降低治疗高血压的成本 遵守治疗，减少白大褂患者不必要的护理 高血压(仅限MD办公室的高血压患者，估计为 20%的患者)，识别不顺从或控制不良的患者， 以及将护理地点从MD的办公室转移到患者的家中。我们的 初始市场：团体员工HMO(1500万人参保，125万人参保 高血压)。

This is a proposal to refine and evaluate a new technology designed to improve hypertension care, at less than the current cost. Hypertension is one of the commonest medical conditions, affecting about heart disease. It cost about $18.7 billion to treat hypertension in the US in 1995. Despite the large number of effective antihypertensive drugs, and clear evidence that their use can reduce morbidity associated with hypertension, only an estimated one in four Americans with high blood pressure has it well controlled. This is a proposal to integrate a clinical-grade electronic home blood pressure monitor with a very low-cost proprietary teletransmission system which we have developed, to enable patients to easily send blood pressure and heart rate data to physicians over ordinary telephone lines. These user-friendly technologies will be imbedded in an automated information management system which will shift the site of care from clinic to home, and improve the ability of both physicians and patients to assess and manage hypertension. We project a $5/month cost to the user for the entire system, including monitor and telecommunications. PROPOSED COMMERCIAL APPLICATION: Our service will allow managed care companies to reduce the cost of treating hypertension by improving patient compliance with therapy, cutting unneeded care for people with White Coat hypertension (high blood pressure only in the MD's office, estimated at 20% of patients), identifying noncompliant or poorly-controlled patients, and shifting the site of care from MD's office to patient's home. Our initial market: group-staff HMOs (15 million covered lives, 1.25 million hypertensives).